Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the...
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation...
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an...
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
Spain’s Council of Ministers has approved a Royal Decree regulating the medicinal use of cannabis preparations in hospital settings.
The first official evaluation of the CanG reforms highlights early trends in market growth, youth use, health outcomes, and crime.
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on...
Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week.
